Bifemelane - Revision history

Prab: CSV import

2025-03-23T11:43:06Z

CSV import

← Older revision		Revision as of 11:43, 23 March 2025
Line 1:		Line 1:
	~~'''Bifemelane''' is a [[nootropic]] and [[vasodilator]] that is~~ used in the treatment of [[cerebrovascular disease]] and [[dementia]]. It was first developed in [[Japan]] and has been in use since the 1980s. Bifemelane is classified as a [[monoamine oxidase inhibitor]] (MAOI), specifically a [[monoamine oxidase A]] (MAO-A) inhibitor.		{{Short description\|A drug used in the treatment of cerebrovascular disorders}}

	~~== Mechanism~~ of ~~Action ==~~		[[File:Bifemelane.svg\|Chemical structure of Bifemelane\|thumb\|right]]

	Bifemelane ~~works by inhibiting~~ the ~~action~~ of ~~monoamine oxidase A, an enzyme that breaks down~~ [[~~neurotransmitters~~]] ~~in the brain~~. ~~By inhibiting this enzyme,~~ Bifemelane ~~increases the levels of these neurotransmitters, which can help~~ to improve cognitive function and ~~memory. It also has vasodilating effects, which can improve blood flow to the brain~~.		'''Bifemelane''' is a [[pharmaceutical drug]] that is primarily used in the treatment of [[cerebrovascular disorders]] and [[depression]]. It is classified as a [[nootropic]] and [[antidepressant]] agent. Bifemelane is known for its ability to improve cognitive function and mood in patients with various neurological conditions.

	== ~~Uses~~ ==		==Pharmacology==
			Bifemelane acts as a selective [[monoamine oxidase inhibitor]] (MAOI), specifically inhibiting the [[MAO-A]] subtype. This action increases the levels of [[neurotransmitters]] such as [[serotonin]], [[norepinephrine]], and [[dopamine]] in the brain, which are crucial for mood regulation and cognitive function. Additionally, Bifemelane has been shown to enhance [[cerebral blood flow]], which may contribute to its therapeutic effects in cerebrovascular disorders.

	Bifemelane is primarily ~~used in~~ the treatment of cerebrovascular ~~disease and dementia. It can help to improve symptoms~~ such as ~~memory loss, confusion, and difficulty concentrating~~. It ~~may~~ also be used ~~in the treatment~~ of [[depression]], as it ~~can increase~~ the ~~levels~~ of ~~neurotransmitters that are often low in people with this condition~~.		==Medical Uses==
			Bifemelane is primarily prescribed for the treatment of symptoms associated with cerebrovascular insufficiency, such as those seen in [[stroke]] patients. It is also used to alleviate symptoms of depression, particularly in elderly patients who may have concurrent cognitive decline. The drug's ability to improve mood and cognitive function makes it a valuable option in the management of these conditions.

	== ~~Side Effects~~ ==		==Mechanism of Action==
			The primary mechanism of action of Bifemelane involves the inhibition of the MAO-A enzyme, leading to increased levels of monoamines in the brain. This results in enhanced neurotransmission and improved mood and cognitive function. Bifemelane also exhibits neuroprotective properties, which may help in preventing further neuronal damage in patients with cerebrovascular disorders.

	~~Like all medications, Bifemelane can cause~~ side effects~~. These may~~ include [[nausea]], [[dizziness]], and [[insomnia]]. ~~In rare cases~~, ~~it can cause more serious side effects such as~~ [[~~hypertension~~]] or [[~~serotonin syndrome~~]].		==Side Effects==
			Common side effects of Bifemelane include [[nausea]], [[dizziness]], and [[insomnia]]. As with other MAOIs, there is a risk of [[hypertensive crisis]] if the drug is taken with certain foods or other medications that increase [[tyramine]] levels. Patients are advised to follow dietary restrictions to avoid such interactions.

	== ~~Contraindications~~ ==		==Related Pages==
			* [[Monoamine oxidase inhibitor]]
	Bifemelane should not be used by people who are allergic to it or to any other MAOIs. It should also not be used by people with certain medical conditions, such as [[pheochromocytoma]] or [[congestive heart failure]], without first consulting a doctor.

	~~== See Also ==~~

	* [[Nootropics]]
	* [[Vasodilators]]
	* [[Monoamine oxidase ~~inhibitors~~]]
	* [[Cerebrovascular disease]]		* [[Cerebrovascular disease]]
	* [[~~Dementia~~]]		* [[Nootropic]]
			* [[Antidepressant]]

	[[Category:~~Pharmacology]]~~		[[Category:Antidepressants]]
	~~[[Category:Medicine~~]]
	[[Category:Nootropics]]		[[Category:Nootropics]]
	~~[[Category:Vasodilators]]~~
	[[Category:Monoamine oxidase inhibitors]]		[[Category:Monoamine oxidase inhibitors]]

	~~{{medicine-stub}}~~
	~~<gallery>~~
	~~File:Bifemelane.svg\|Bifemelane~~
	~~</gallery>~~
	~~<gallery>~~
	~~File:Bifemelane.svg\|Bifemelane~~
	~~</gallery>~~

Prab: CSV import

2025-02-20T00:49:23Z

CSV import

← Older revision		Revision as of 00:49, 20 February 2025
Line 32:		Line 32:

	{{medicine-stub}}		{{medicine-stub}}
			<gallery>
			File:Bifemelane.svg\|Bifemelane
			</gallery>
	<gallery>		<gallery>
	File:Bifemelane.svg\|Bifemelane		File:Bifemelane.svg\|Bifemelane
	</gallery>		</gallery>

Prab: CSV import

2025-02-20T00:47:24Z

CSV import

← Older revision		Revision as of 00:47, 20 February 2025
Line 32:		Line 32:

	{{medicine-stub}}		{{medicine-stub}}
			<gallery>
			File:Bifemelane.svg\|Bifemelane
			</gallery>

Prab: CSV import

2024-03-10T19:31:22Z

CSV import

New page

'''Bifemelane''' is a [[nootropic]] and [[vasodilator]] that is used in the treatment of [[cerebrovascular disease]] and [[dementia]]. It was first developed in [[Japan]] and has been in use since the 1980s. Bifemelane is classified as a [[monoamine oxidase inhibitor]] (MAOI), specifically a [[monoamine oxidase A]] (MAO-A) inhibitor.

== Mechanism of Action ==

Bifemelane works by inhibiting the action of monoamine oxidase A, an enzyme that breaks down [[neurotransmitters]] in the brain. By inhibiting this enzyme, Bifemelane increases the levels of these neurotransmitters, which can help to improve cognitive function and memory. It also has vasodilating effects, which can improve blood flow to the brain.

== Uses ==

Bifemelane is primarily used in the treatment of cerebrovascular disease and dementia. It can help to improve symptoms such as memory loss, confusion, and difficulty concentrating. It may also be used in the treatment of [[depression]], as it can increase the levels of neurotransmitters that are often low in people with this condition.

== Side Effects ==

Like all medications, Bifemelane can cause side effects. These may include [[nausea]], [[dizziness]], and [[insomnia]]. In rare cases, it can cause more serious side effects such as [[hypertension]] or [[serotonin syndrome]].

== Contraindications ==

Bifemelane should not be used by people who are allergic to it or to any other MAOIs. It should also not be used by people with certain medical conditions, such as [[pheochromocytoma]] or [[congestive heart failure]], without first consulting a doctor.

== See Also ==

* [[Nootropics]]
* [[Vasodilators]]
* [[Monoamine oxidase inhibitors]]
* [[Cerebrovascular disease]]
* [[Dementia]]

[[Category:Pharmacology]]
[[Category:Medicine]]
[[Category:Nootropics]]
[[Category:Vasodilators]]
[[Category:Monoamine oxidase inhibitors]]

{{medicine-stub}}